中华创伤骨科杂志
中華創傷骨科雜誌
중화창상골과잡지
CHINESE JOURNAL OF ORTHOPAEDIC TRAUMA
2014年
9期
750-754
,共5页
王大川%王峰%王乃国%谭炳毅%丰荣杰%袁泽农
王大川%王峰%王迺國%譚炳毅%豐榮傑%袁澤農
왕대천%왕봉%왕내국%담병의%봉영걸%원택농
骨质疏松%骨折%矫形外科手术%Kümmell病
骨質疏鬆%骨摺%矯形外科手術%Kümmell病
골질소송%골절%교형외과수술%Kümmell병
Osteoporosis%Fractures,bone%Orthopedic procedures%Kümmell's disease
目的 探讨经椎弓根椎体内植骨联合椎弓根螺钉内固定治疗Ⅲa、Ⅲb期Kümmell病的疗效. 方法 2006年11月至2011年12月收治Ⅲ期Kümmell病患者15例,根据术前神经症状、神经压迫来源将Ⅲ期患者进一步划分为3个亚型:Ⅲa型2例,Ⅲb型6例,Ⅲc型7例.将Ⅲa型和Ⅲb型共8例患者纳入本研究,男3例,女5例;年龄57 ~ 79岁,平均71.1岁;采用经椎弓根椎体内植骨联合后路椎弓根螺钉内固定手术治疗;分别于术前及术后半年测定疼痛视觉模拟评分(VAS),并测量后凸cobb角、骨折椎体前、后缘高度及椎体楔形角变化. 结果 所有患者均获随访,时间18 ~66个月(平均33.5个月).平均手术时间157 min(110 ~190 min),平均失血量450 mL(350~800 mL),神经功能损伤Frankel分级由术前C级5例、D级1例、E级2例改善为术后E级6例、D级2例.VAS评分术后较术前降低,术后后凸cobb角、椎体前缘高度、椎体楔形角均获明显恢复.随访中观察到椎体前缘高度和椎体楔形角有丢失,椎体后缘高度在术前、术后及随访中无明显变化. 结论 对于Kümmell病的Ⅲa和Ⅲb两种亚型,经椎弓根椎体内植骨联合椎弓根螺钉内固定是一种简便、安全、有效的治疗方法,可以获得良好的矫形率及症状缓解率.
目的 探討經椎弓根椎體內植骨聯閤椎弓根螺釘內固定治療Ⅲa、Ⅲb期Kümmell病的療效. 方法 2006年11月至2011年12月收治Ⅲ期Kümmell病患者15例,根據術前神經癥狀、神經壓迫來源將Ⅲ期患者進一步劃分為3箇亞型:Ⅲa型2例,Ⅲb型6例,Ⅲc型7例.將Ⅲa型和Ⅲb型共8例患者納入本研究,男3例,女5例;年齡57 ~ 79歲,平均71.1歲;採用經椎弓根椎體內植骨聯閤後路椎弓根螺釘內固定手術治療;分彆于術前及術後半年測定疼痛視覺模擬評分(VAS),併測量後凸cobb角、骨摺椎體前、後緣高度及椎體楔形角變化. 結果 所有患者均穫隨訪,時間18 ~66箇月(平均33.5箇月).平均手術時間157 min(110 ~190 min),平均失血量450 mL(350~800 mL),神經功能損傷Frankel分級由術前C級5例、D級1例、E級2例改善為術後E級6例、D級2例.VAS評分術後較術前降低,術後後凸cobb角、椎體前緣高度、椎體楔形角均穫明顯恢複.隨訪中觀察到椎體前緣高度和椎體楔形角有丟失,椎體後緣高度在術前、術後及隨訪中無明顯變化. 結論 對于Kümmell病的Ⅲa和Ⅲb兩種亞型,經椎弓根椎體內植骨聯閤椎弓根螺釘內固定是一種簡便、安全、有效的治療方法,可以穫得良好的矯形率及癥狀緩解率.
목적 탐토경추궁근추체내식골연합추궁근라정내고정치료Ⅲa、Ⅲb기Kümmell병적료효. 방법 2006년11월지2011년12월수치Ⅲ기Kümmell병환자15례,근거술전신경증상、신경압박래원장Ⅲ기환자진일보화분위3개아형:Ⅲa형2례,Ⅲb형6례,Ⅲc형7례.장Ⅲa형화Ⅲb형공8례환자납입본연구,남3례,녀5례;년령57 ~ 79세,평균71.1세;채용경추궁근추체내식골연합후로추궁근라정내고정수술치료;분별우술전급술후반년측정동통시각모의평분(VAS),병측량후철cobb각、골절추체전、후연고도급추체설형각변화. 결과 소유환자균획수방,시간18 ~66개월(평균33.5개월).평균수술시간157 min(110 ~190 min),평균실혈량450 mL(350~800 mL),신경공능손상Frankel분급유술전C급5례、D급1례、E급2례개선위술후E급6례、D급2례.VAS평분술후교술전강저,술후후철cobb각、추체전연고도、추체설형각균획명현회복.수방중관찰도추체전연고도화추체설형각유주실,추체후연고도재술전、술후급수방중무명현변화. 결론 대우Kümmell병적Ⅲa화Ⅲb량충아형,경추궁근추체내식골연합추궁근라정내고정시일충간편、안전、유효적치료방법,가이획득량호적교형솔급증상완해솔.
Objective To evaluate the posterior transpedicle intracorporeal bone grafting combined with segmental pedicle screw fixation for stage Ⅲ Kümmell' s disease.Methods Fifteen patients with stage Ⅲ Kümmell' s disease were treated in our department from November 2006 to December 2011.On the basis of the staging system put forward by Li et al,we further classified stage Ⅲ Kümmell's disease into 3 subtypes:Ⅲ a without any neurological deficit,vertebral posterior cortex collapse,encroachment on the spinal canal by midsection posterior cortex,or breakage of superior and inferior endplates; Ⅲ b,with radiologic features similar to Ⅲa except pre-operative neurological compromise; Ⅲ c,with apparent pre-operative neurological compromise,superior or inferior endplate breakage,encroachment on the spinal canal by posterior superior or posterior inferior corner of the collapsed vertebra.Included in the present study were 8 cases of subtypes Ⅲa and Ⅲ b.They received posterior transpedicle intracorporeal bone grafting combined with segmental pedicle screw fixation.Their lateral cobb angle,anterior and posterior vertebral height,wedge angle,and visual analogue scale(VAS) were measured preoperatively and 6 months postoperatively to evaluate the results.Results The 8 patients were followed up from 18 to 66 months (mean,33.5 months).Mean operation time was 157 minutes (from 110 to 190 minutes).Mean blood loss was 450 mL (from 350 to 800 mL).Frankel classification was improved from 5 C,1 D,and 2 E preoperatively to 6 E and 2 D postoperatively.Their VAS score decreased after operation.Although loss of correction of anterior vertebral height and wedge angle was observed at the final visit,no significant differences in the posterior vertebral height were observed between pre-operation,immediate post-operation and the final visit.Conclusion For patients with stage Ⅲ Kümmell's disease of subtypes Ⅲa and Ⅲ b,posterior transpedicle intracorpareal bone grafting combined with segmental pedicle screw fixation is the optimal selection,which can effectively relieve back pain,achieve good correction of kyphosis,and lead to clinical success.